Rinauro, Dillon J.
Chiti, Fabrizio
Vendruscolo, Michele
Limbocker, Ryan https://orcid.org/0000-0002-6030-6656
Funding for this research was provided by:
Centre for Misfolding Diseases
DEVCOM-ARL
DTRA (SARI)
Regione Toscana (Project PRAMA)
Article History
Received: 2 March 2023
Accepted: 17 August 2023
First Online: 20 February 2024
Declarations
:
: This study did not directly involve human participants, human data or human tissue and therefore did not require ethical approval or consent for participation.
: Not applicable.
: M.V. is a co-founder of Wren Therapeutics Limited, which is pursuing inhibitors of protein misfolding and aggregation. The remaining authors declare no competing interests. The views expressed herein are those of the authors and do not reflect the position of the United States Military Academy, the Department of the Army, or the Department of Defense.